Resources
NPLB partners with leading health economists, innovators, investors, and academics to conduct research and generate insights that help everyone understand healthcare and the biomedical innovation ecosystem.
Our team builds on this work to create clear and concise explainers, videos, and other materials that advance our mission to defend biomedical affordability and innovation.
Presentations
FEATURED WEBINAR
How the IRA makes new small molecule biotech R&D uninvestable for diseases of aging
By price setting small molecule medicines after only 9 years on the market, the Inflation Reduction Act threatens investments in future cures. The law’s disparate treatment of small and large molecules will warp R&D and result in fewer new cures, particularly those for cancer and other diseases of aging.
Videos
FEATURED VIDEO
The Value of Medicines
Medicines do so much more than help the patient that's treated today. Considering a drug's societal value shows we may value them a lot more than we had thought.
Research
FEATURED RESEARCH
Getting the math right when measuring the value of new medicines
Cost-effectiveness analysis (CEA) is commonly used to inform the assessment of value from new healthcare technologies. However, traditional CEA methods often fail to capture important elements of a medicine’s or other medical technology’s societal value. New research using updated & better math found that taking even some of these “petals of the value flower” into account reveals that a medicine is often much more cost-effective than previously appreciated.
Advocacy
FEATURED CONTENT
Do more for patients, preserve innovation: Fix the Inflation Reduction Act
1000+ Investors, researchers, patients, & innovators urge critical fixes to Senate Rx Bill that can, in a budget neutral way, lower Medicare Rx out-of-pocket costs and preserve biomedical research and development of both small molecule treatments and biologics.
We’re building support across the biotech ecosystem
BECOME A FIRST RESPONDER & THOUGHT PARTNER
Sign up to receive action alerts. Help protect access to lifesaving medicines & preserve innovation for those still waiting for a cure.